Kiniksa Announces U.S. FDA Acceptance of sBLA and Priority Review for Rilonacept in Recurrent Pericarditis

NEXT STORY
Generex and NuGenerex Immuno-Oncology Ii-Key-SARS-CoV-2 Vaccine Partner Bintai Kinden Executes its Exclusive Distribution & Licensing Option for Australia and New Zealand
PREV STORY
Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 From Amgen
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Dr. Asima K. Ahmad Joins Fertility Centers of Illinois

Physician team grows to 11 at nationally and internationally-recognized Chicagoland fertility center with 35,000 ...

author_avatar
NASDAQ Market News

Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia

MELBOURNE, Australia and DRESDEN, Germany, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited ...

author_avatar
NASDAQ Market News

Chembio Diagnostics Appoints Dr. Mary Lake Polan to its Board of Directors

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader ...

author_avatar
NASDAQ Market News